口服霍乱活疫苗：两种菌株对人体临床有效性的评估。
Live oral cholera vaccine: evaluation of the clinical effectiveness of two strains in humans.
作者信息
Cash R A, Music S I, Libonati J P, Schwartz A R, Hornick R B
出版信息
Infect Immun. 1974 Oct;10(4):762-4. doi: 10.1128/iai.10.4.762-764.1974.
Abstract
El Tor Ogawa C14-S5 and EW-6, two live vaccine candidate strains, were given to volunteers in varying doses with and without bicarbonate. Vibrios were found in the stool of one of 32 men given the vaccine strain, and only three men developed a significant titer rise (fourfold or greater) at 2 weeks of vibriocidal or antitoxic antibody. Five men who had previously received 10(9) organisms of the C14-S5 strain were challenged subsequently with virulent Ogawa 395 Vibrio cholerae. The rate of clinical infection in these men was no different than in unvaccinated controls. It was demonstrated that the live oral cholera vaccines did not remain viable in the intestine long enough to act antigenically.
摘要
两种活疫苗候选菌株，即埃尔托小川型C14 - S5和EW - 6，以不同剂量给予志愿者，有的加了碳酸氢盐，有的没加。在接种疫苗菌株的32名男性中，有1人的粪便中发现了弧菌，只有3人在2周时杀菌或抗毒素抗体出现显著滴度升高（四倍或更高）。5名之前接种过10⁹个C14 - S5菌株菌体的男性随后受到强毒小川型霍乱弧菌395的攻击。这些男性的临床感染率与未接种疫苗的对照组没有差异。结果表明，口服活霍乱疫苗在肠道内存活时间不够长，无法发挥抗原作用。
相似文献
1
Live oral cholera vaccine: evaluation of the clinical effectiveness of two strains in humans.口服霍乱活疫苗：两种菌株对人体临床有效性的评估。
Infect Immun. 1974 Oct;10(4):762-4. doi: 10.1128/iai.10.4.762-764.1974.
2
The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.候选疫苗霍乱弧菌638对健康志愿者具有霍乱预防作用。
Infect Immun. 2005 May;73(5):3018-24. doi: 10.1128/IAI.73.5.3018-3024.2005.
3
Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru.在美国和秘鲁成年志愿者中对一种二价（CVD 103-HgR/CVD 111）口服霍乱活疫苗的评估。
Infect Immun. 1997 Sep;65(9):3852-6. doi: 10.1128/iai.65.9.3852-3856.1997.
4
Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae.口服霍乱活疫苗候选株CVD 110（埃尔托小川型霍乱弧菌的ctxA缺失、zot缺失、ace缺失衍生物）的安全性和免疫原性
J Infect Dis. 1993 Dec;168(6):1536-40. doi: 10.1093/infdis/168.6.1536.
5
Efficacy of a live oral cholera vaccine in human volunteers.一种口服霍乱活疫苗在人体志愿者中的效力
Dev Biol Stand. 1976;33:108-12.
6
Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate.德克萨斯之星-SR：减毒口服霍乱弧菌候选疫苗
Dev Biol Stand. 1983;53:59-65.
7
Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.单剂量口服霍乱活疫苗CVD 103-HgR接种三个月后，用霍乱弧菌O1 El tor稻叶型毒株攻击，预防霍乱效果的随机、双盲、安慰剂对照、多中心试验。
Infect Immun. 1999 Dec;67(12):6341-5. doi: 10.1128/IAI.67.12.6341-6345.1999.
8
Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults.霍乱活口服疫苗株CVD 103-HgR在泰国健康成年人中的安全性和免疫原性的初步评估。
Infect Immun. 1989 Nov;57(11):3261-4. doi: 10.1128/iai.57.11.3261-3264.1989.
9
Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108.安全、活口服霍乱弧菌候选疫苗IEM108的构建与评价
Infect Immun. 2003 Oct;71(10):5498-504. doi: 10.1128/IAI.71.10.5498-5504.2003.
10
Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR.口服霍乱活疫苗CVD 103-HgR接种后，受挑战志愿者体内保护性免疫的起始和持续时间。
J Infect Dis. 1992 Oct;166(4):837-41. doi: 10.1093/infdis/166.4.837.
引用本文的文献
1
Oral vaccines for preventing cholera.用于预防霍乱的口服疫苗。
Cochrane Database Syst Rev. 2011 Mar 16;2011(3):CD008603. doi: 10.1002/14651858.CD008603.pub2.
2
Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine.减毒霍乱弧菌埃尔托小川型菌株德州之星-SR作为口服活疫苗的人体评估。
Infect Immun. 1984 Feb;43(2):515-22. doi: 10.1128/iai.43.2.515-522.1984.
3
New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.应用于疫苗研发的细菌性肠道感染发病机制新知识。
Microbiol Rev. 1983 Dec;47(4):510-50. doi: 10.1128/mr.47.4.510-550.1983.
4
Cell surface characteristics of environmental and clinical isolates of Vibrio cholerae non-O1.霍乱弧菌非O1群环境及临床分离株的细胞表面特征
Appl Environ Microbiol. 1992 Nov;58(11):3567-73. doi: 10.1128/aem.58.11.3567-3573.1992.
5
Attenuation of virulence by P and V plasmids in Vibrio cholerae: strains suitable for oral immunization.霍乱弧菌中P质粒和V质粒对毒力的减弱作用：适用于口服免疫的菌株
Bull World Health Organ. 1979;57(4):643-7.
本文引用的文献
1
PRELIMINARY STUDIES ON THE DEVELOPMENT OF A LIVE ORAL VACCINE FOR ANTI-CHOLERA IMMUNIZATION.用于抗霍乱免疫的口服活疫苗研发的初步研究
Bull World Health Organ. 1963;29(6):753-66.
2
Production of antitoxic immunity by live oral cholera vaccine.口服霍乱活疫苗产生抗毒素免疫力。
J Bacteriol. 1968 Jan;95(1):255-6. doi: 10.1128/jb.95.1.255-256.1968.
3
Titration of cholera antitoxin in human sera by microhemagglutination with formalinized erythrocytes.用甲醛化红细胞微血凝试验滴定人血清中的霍乱抗毒素
Appl Microbiol. 1970 May;19(5):742-5. doi: 10.1128/am.19.5.742-745.1970.
4
Live oral cholera vaccine: report of a trial on human volunteer subjects.口服霍乱活疫苗：人体志愿者试验报告。
Bull World Health Organ. 1969 Apr;40(4):503-11.
5
A controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in the Philippines.菲律宾霍乱及埃尔托霍乱疫苗有效性的对照现场试验。
Bull World Health Organ. 1967;37(5):703-27.
6
Further studies on the development of a live oral cholera vaccine.口服霍乱活疫苗研发的进一步研究
J Hyg (Lond). 1968 Jun;66(2):307-18. doi: 10.1017/s0022172400041164.
7
A prototype live oral cholera vaccine.
Nature. 1971 Mar 12;230(5289):97-9. doi: 10.1038/230097a0.
8
Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum.人类对霍乱弧菌感染的反应。一、对已知接种物的临床、血清学和细菌学反应。
J Infect Dis. 1974 Jan;129(1):45-52. doi: 10.1093/infdis/129.1.45.
Zotero 插件